Clinical considerations and surgical outcomes of breast implant-associated cancer: An emerging disease of interest

Breast cancer continues to be one of the main priorities in global health and public health, remains most frequent deadly malignant neoplasm women worldwide. implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare type non-Hodgkin's lymphoma, whose pathogenesis pathophysiology are not well known, but which seen with increasing frequency due increase cosmetic procedures. To date, there limitations terms knowledge about clinical behavior disease, can manifest itself many forms, variable evolution time uncertain surgical outcomes medium- long-term. Based on above, aim this review summarize evidence considerations breast facilitate identification management condition. A bibliographic search was performed engines databases PubMed, ScienceDirect, Embase, EBSCO MEDLINE. Within considerations, implant used (textured), history, severity manifestations, staging, must taken into account order determine opportunity for intervention neoadjuvant therapy, try guarantee survival avoid recurrence. Patients who undergo complete capsulectomy radiotherapy have better outcomes.